Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. H.W.G.M. (Erik) Boddeke
University Medical Center Groningen

prof. dr. H.W.G.M. (Erik) Boddeke

Profile picture of prof. dr. H.W.G.M. (Erik) Boddeke

Erik Boddeke is professor of Medical Physiology/Neurophysiology. From 1988 until 1995 he was head of a research laboratory and group leader at Sandoz and at Novartis Research in Basel, Switzerland. Since 1998 he is professor of Physiology at the University Medical Center Groningen (UMCG). During the period 2000-2015 he was head of the Neuroscience Research department (UMCG) and from 2009 until 2015 director of the University of Groningen Neuroscience Research School BCN. His work focusses on glia and ageing and on neural stem cells. Professor Boddeke has successfully supervised more than 25 PhD student projects and he has more than 200 publications to his name. Since May 2015 he has been appointed as Dean of Research at the UMCG.

Curriculum vitae

Prof. H.W.G.M. Boddeke



Institution and location

Master Pharmacy MSc, University of Amsterdam, Faculty natural sciences, 1984

PhD Pharmacology, University of Amsterdam, Faculty of natural sciences, 1987

Dr Habil Physiology, University of Freiburg, faculty of Medicine, 1997               

Research and Professional Experience

1987 -1988, Post-doctoral fellow, Janssen Pharmaceutica, Dusseldorf, Germany

1988 - 1996, Lab head, Dept. Neuroscience, Sandoz Ltd., Basle, Switzerland

1996 - 1998, Deputy Head of Dept. of Genetics, Novartis Ltd., Basle, Switzerland

1998 - present, Professor of Medical Physiology, UMCG, Groningen

2000 - 2007, Head of Dept. Medical Physiology, UMCG, Groningen

2007 - 2015, Head of Dept. Neurosciences, UMCG, Groningen

2010 - 2015, Director of Research School BCN, Groningen

2015 - present, Dean of Research, UMCG, Groningen


Scientific Boards

2005 - 2011, Dutch MS Research Foundation Scientific Advisory Board

2008 - 2012, Dutch Physiological Society: Scientific Board

2011, Chair of the SEP evaluation board of the Neuroscience Campus, VUMC

Since 2012, Treasurer of the European Network Glia research

Since 2012, Netherlands Institute for Neuroscience (NIN) Scientific advisory board

2013, Accreditation Board: Psychobiology- Neuroscience Bachelor, UvA

Since 2014, Wellcome Trust Scientific Advisory Board

Since 2014, Scientific advisor for Lundbeck

Since 2014, CEHA (Copenhagen Institute for Healthy Aging) Scientific Advisory Board

Member of international organizing committees

2005, 7th  European Glia Meeting Amsterdam, NL

2011, 5th joined ECTRIMS/ACTRIMS meeting in Amsterdam

2011- present, Treasurer of the European Glia Society

2013, 11th European Glia Meeting, Berlin, Germany

2015, 12th European Glia Meeting, Bilbao, Spain


Editorial Board member

- Naunyn Schmiedeberg’s Arch. Pharmacol.

- Glia

- Neuroimmunology and Neuroinflammation



S. Amor, Dept. Pathology VUMC: research on post mortem MS patient brain tissue

I. Huitinga, KNAW Netherlands Brain Institute, NL: neuroimmunology

J. Hoeijmakers, Dept. Genetics, Erasmus MC, NL: research on Brain Aging

D. Baker, The Blizzard Institute, London, UK: research on progressive MS

H. Kettenmann, MDC, Berlin, GE: microglia physiology

M. Prinz, Dept. Pathology, University Freiburg, GE: neuroimmunology

A. Mir, Novartis Pharma AG, Inst. Biomedical Research, Basle, Switzerland: neuroimmunology

K. Bhat, The MD Anderson, Cancer Center, Houston, USA: research on glioma immunology

J. Miller, The Allan Brain Institute, Seattle, USA: bioinformatics

T. Moeller, Dept. Neurophamacology, Lundbeck Research, Paramus, USA: microglia pharmacology

R. Ransohoff, Dept. Neuroimmunology, Biogen Idec, Cambridge MA, USA: neuroimmunology

B. Mc Vicar, Dept. Physiology, University of British Columbia, CA: microglia physiology

S. Marie, Dept. Dept. Neurology, University Sao Paulo, BR: microglia pathology


International Ageing Brain Network containing the U4 Universities (the Universities of Groningen, Goettingen, Gent and Uppsala) as well as the Universities of Newcastle, Copenhagen and Bristish Columbia and the Mayo Clinic. 

Last modified:25 June 2022 01.32 a.m.